Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49. https://doi.org/10.3322/caac.21660.
Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet 2020;396:635–48. https://doi.org/10.1016/S0140-6736(20)31288-5
Barchi LC, Ramos M, Yagi OK, Mucerino DR, Bresciani CJC, Ribeiro JU, et al. Brazilian gastric cancer association guidelines (Part 1): An update on diagnosis, staging, endoscopic treatment and follow-up. Arq Bras Cir Dig. 2020;33:e1535 https://doi.org/10.1590/0102-672020200003e1535
Wagner AD, Lordick F, Grabsch HI, Terashima M, Terada M, Yoshikawa T, et al. Multidisciplinary management of stage II-III gastric and gastro-oesophageal junction cancer. Eur J Cancer. 2020;124:67–76. https://doi.org/10.1016/j.ejca.2019.09.006
Szor DJ, Dias AR, Pereira MA, Ramos M, Zilberstein B, Cecconello I, et al. Prognostic role of neutrophil/lymphocyte ratio in resected gastric cancer: A systematic review and meta-analysis. Clin (Sao Paulo). 2018;73:e360 https://doi.org/10.6061/clinics/2018/e360
Borggreve AS, den Boer RB, van Boxel GI, de Jong PA, Veldhuis WB, Steenhagen E, et al. The predictive value of low muscle mass as measured on CT scans for postoperative complications and mortality in gastric cancer patients: A systematic review and meta-analysis. J Clin Med. 2020;9:199 https://doi.org/10.3390/jcm9010199
Aleixo GFP, Shachar SS, Nyrop KA, Muss HB, Malpica L, Williams GR. Myosteatosis and prognosis in cancer: Systematic review and meta-analysis. Crit Rev Oncol Hematol. 2020;145:102839 https://doi.org/10.1016/j.critrevonc.2019.102839
Sjostrom L. A computer-tomography based multicompartment body composition technique and anthropometric predictions of lean body mass, total and subcutaneous adipose tissue. Int J Obes. 1991;15:19–30.
Miller KD, Jones E, Yanovski JA, Shankar R, Feuerstein I, Falloon J. Visceral abdominal-fat accumulation associated with use of indinavir. Lancet 1998;351:871–5. https://doi.org/10.1016/S0140-6736(97)11518-5
Aubrey J, Esfandiari N, Baracos VE, Buteau FA, Frenette J, Putman CT, et al. Measurement of skeletal muscle radiation attenuation and basis of its biological variation. Acta Physiol (Oxf). 2014;210:489–97. https://doi.org/10.1111/apha.12224
Bhullar AS, Anoveros-Barrera A, Dunichand-Hoedl A, Martins K, Bigam D, Khadaroo RG, et al. Lipid is heterogeneously distributed in muscle and associates with low radiodensity in cancer patients. J Cachexia Sarcopenia Muscle. 2020;11:735–47. https://doi.org/10.1002/jcsm.12533
Correa-de-Araujo R, Addison O, Miljkovic I, Goodpaster BH, Bergman BC, Clark RV, et al. Myosteatosis in the context of skeletal muscle function deficit: An interdisciplinary workshop at the national institute on aging. Front Physiol. 2020;11:963 https://doi.org/10.3389/fphys.2020.00963
Sjoblom B, Gronberg BH, Wentzel-Larsen T, Baracos VE, Hjermstad MJ, Aass N, et al. Skeletal muscle radiodensity is prognostic for survival in patients with advanced non-small cell lung cancer. Clin Nutr. 2016;35:1386–93. https://doi.org/10.1016/j.clnu.2016.03.010
Akahori T, Sho M, Kinoshita S, Nagai M, Nishiwada S, Tanaka T, et al. Prognostic significance of muscle attenuation in pancreatic cancer patients treated with neoadjuvant chemoradiotherapy. World J Surg. 2015;39:2975–82. https://doi.org/10.1007/s00268-015-3205-3
Xiao J, Caan BJ, Cespedes Feliciano EM, Meyerhardt JA, Peng PD, Baracos VE, et al. Association of low muscle mass and low muscle radiodensity with morbidity and mortality for colon cancer surgery. JAMA Surg. 2020;155:942–9. https://doi.org/10.1001/jamasurg.2020.2497
Sachs S, Zarini S, Kahn DE, Harrison KA, Perreault L, Phang T, et al. Intermuscular adipose tissue directly modulates skeletal muscle insulin sensitivity in humans. Am J Physiol Endocrinol Metab. 2019;316:E866–79. https://doi.org/10.1152/ajpendo.00243.2018
Krssak M, Falk Petersen K, Dresner A, DiPietro L, Vogel SM, Rothman DL, et al. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia. 1999;42:113–6. https://doi.org/10.1007/s001250051123
Hayashi N, Ando Y, Gyawali B, Shimokata T, Maeda O, Fukaya M, et al. Low skeletal muscle density is associated with poor survival in patients who receive chemotherapy for metastatic gastric cancer. Oncol Rep. 2016;35:1727–31. https://doi.org/10.3892/or.2015.4475
Eo W, Kwon J, An S, Lee S, Kim S, Nam D, et al. Clinical significance of paraspinal muscle parameters as a prognostic factor for survival in gastric cancer patients who underwent curative surgical resection. J Cancer. 2020;11:5792–801. https://doi.org/10.7150/jca.46637
Hacker UT, Hasenclever D, Linder N, Stocker G, Chung HC, Kang YK, et al. Prognostic role of body composition parameters in gastric/gastroesophageal junction cancer patients from the EXPAND trial. J Cachexia Sarcopenia Muscle. 2020;11:135–44. https://doi.org/10.1002/jcsm.12484
Zhuang CL, Shen X, Huang YY, Zhang FM, Chen XY, Ma LL, et al. Myosteatosis predicts prognosis after radical gastrectomy for gastric cancer: A propensity score-matched analysis from a large-scale cohort. Surgery 2019;166:297–304. https://doi.org/10.1016/j.surg.2019.03.020
Dolan RD, Lim J, McSorley ST, Horgan PG, McMillan DC. The role of the systemic inflammatory response in predicting outcomes in patients with operable cancer: Systematic review and meta-analysis. Sci Rep. 2017;7:16717 https://doi.org/10.1038/s41598-017-16955-5
Dolan RD, McSorley ST, Horgan PG, Laird B, McMillan DC. The role of the systemic inflammatory response in predicting outcomes in patients with advanced inoperable cancer: Systematic review and meta-analysis. Crit Rev Oncol Hematol. 2017;116:134–46. https://doi.org/10.1016/j.critrevonc.2017.06.002
Dolan RD, Daly LE, Simmons CP, Ryan AM, Sim WM, Fallon M, et al. The relationship between ECOG-PS, mGPS, BMI/WL grade and body composition and physical function in patients with advanced cancer. Cancers (Basel). 2020;12:1187 https://doi.org/10.3390/cancers12051187
Feliciano EMC, Kroenke CH, Meyerhardt JA, Prado CM, Bradshaw PT, Kwan ML, et al. Association of systemic inflammation and sarcopenia with survival in nonmetastatic colorectal cancer: Results from the C SCANS study. JAMA Oncol. 2017;3:e172319 https://doi.org/10.1001/jamaoncol.2017.2319
Gabiatti CTB, Martins MCL, Miyazaki DL, Silva LP, Lascala F, Macedo LT, et al. Myosteatosis in a systemic inflammation-dependent manner predicts favorable survival outcomes in locally advanced esophageal cancer. Cancer Med. 2019;8:6967–76. https://doi.org/10.1002/cam4.2593
Amin MB, American Joint Committee on Cancer, American Cancer Society. AJCC cancer staging manual. Eight edition / editor-in-chief, Mahul B. Amin, MD, FCAP; editors, Stephen B. Edge, MD, FACS and 16 others; Donna M. Gress, RHIT, CTR – Technical editor; Laura R. Meyer, CAPM – Managing editor. ed. Chicago IL: American Joint Committee on Cancer, Springer, 2017.
Mitsiopoulos N, Baumgartner RN, Heymsfield SB, Lyons W, Gallagher D, Ross R. Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography. J Appl Physiol (1985). 1998;85:115–122. https://doi.org/10.1152/jappl.1998.85.1.115
Camus V, Lanic H, Kraut J, Modzelewski R, Clatot F, Picquenot JM, et al. Prognostic impact of fat tissue loss and cachexia assessed by computed tomography scan in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapy. Eur J Haematol. 2014;93:9–18. https://doi.org/10.1111/ejh.12285
Heymsfield SB, Wang Z, Baumgartner RN, Ross R. Human body composition: Advances in models and methods. Annu Rev Nutr. 1997;17:527–558. https://doi.org/10.1146/annurev.nutr.17.1.527
Martin L, Birdsell L, Macdonald N, Reiman T, Clandinin MT, McCargar LJ, et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol. 2013;31:1539–47. https://doi.org/10.1200/JCO.2012.45.2722
Doyle SL, Bennett AM, Donohoe CL, Mongan AM, Howard JM, Lithander FE, et al. Establishing computed tomography-defined visceral fat area thresholds for use in obesity-related cancer research. Nutr Res. 2013;33:171–9. https://doi.org/10.1016/j.nutres.2012.12.007
Templeton AJ, Ace O, McNamara MG, Al-Mubarak M, Vera-Badillo FE, Hermanns T, et al. Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysis. Cancer Epidemiol Biomark Prev. 2014;23:1204–12. https://doi.org/10.1158/1055-9965.EPI-14-0146
Kolaczkowska E, Kubes P. Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol. 2013;13:159–75. https://doi.org/10.1038/nri3399
Sun X, Liu X, Liu J, Chen S, Xu D, Li W, et al. Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I-II gastric cancer. Chin J Cancer. 2016;35:57 https://doi.org/10.1186/s40880-016-0122-2
Lin JX, Lin JP, Xie JW, Wang JB, Lu J, Chen QY, et al. Prognostic value and association of sarcopenia and systemic inflammation for patients with gastric cancer following radical gastrectomy. Oncologist 2019;24:e1091–e101. https://doi.org/10.1634/theoncologist.2018-0651
Contal C, O’Quigley J. An application of changepoint methods in studying the effect of age on survival in breast cancer. Computational Stat Data Anal. 1999;30:253–70. https://doi.org/10.1016/S0167-9473(98)00096-6
Caan BJ, Meyerhardt JA, Kroenke CH, Alexeeff S, Xiao J, Weltzien E, et al. Explaining the obesity paradox: The association between body composition and colorectal cancer survival (C-SCANS Study). Cancer Epidemiol Biomark Prev. 2017;26:1008–15. https://doi.org/10.1158/1055-9965.EPI-17-0200
da Cunha ADJ, Silveira MN, Takahashi MES, de Souza EM, Mosci C, Ramos CD, et al. Adipose tissue radiodensity: A new prognostic biomarker in people with multiple myeloma. Nutrition. 2021;86:111141 https://doi.org/10.1016/j.nut.2021.111141
da Cunha Junior AD, Silveira MN, Takahashi MES, de Souza EM, Mosci C, Ramos CD, et al. Visceral adipose tissue glucose uptake is linked to prognosis in multiple myeloma patients: An exploratory study. Clin Nutr. 2021. https://doi.org/10.1016/j.clnu.2021.02.010
Ebadi M, Moctezuma-Velazquez C, Meza-Junco J, Baracos VE, DunichandHoedl AR, Ghosh S, et al. Visceral adipose tissue radiodensity is linked to prognosis in hepatocellular carcinoma patients treated with selective internal radiation therapy. Cancers (Basel). 2020;12:306 https://doi.org/10.3390/cancers12020356
Tegels JJ, van Vugt JL, Reisinger KW, Hulsewe KW, Hoofwijk AG, Derikx JP, et al. Sarcopenia is highly prevalent in patients undergoing surgery for gastric cancer but not associated with worse outcomes. J Surg Oncol. 2015;112:403–7. https://doi.org/10.1002/jso.24015
Daly LE, Ni Bhuachalla EB, Power DG, Cushen SJ, James K, Ryan AM. Loss of skeletal muscle during systemic chemotherapy is prognostic of poor survival in patients with foregut cancer. J Cachexia Sarcopenia Muscle. 2018;9:315–25. https://doi.org/10.1002/jcsm.12267
Miyamoto Y, Baba Y, Sakamoto Y, Ohuchi M, Tokunaga R, Kurashige J, et al. Sarcopenia is a negative prognostic factor after curative resection of colorectal cancer. Ann Surg Oncol. 2015;22:2663–8. https://doi.org/10.1245/s10434-014-4281-6
da Cunha LP, Silveira MN, Mendes MCS, Costa FO, Macedo LT, de Siqueira NS, et al. Sarcopenia as an independent prognostic factor in patients with metastatic colorectal cancer: A retrospective evaluation. Clin Nutr ESPEN. 2019;32:107–12. https://doi.org/10.1016/j.clnesp.2019.04.004
Hamrick MW, McGee-Lawrence ME, Frechette DM. Fatty infiltration of skeletal muscle: Mechanisms and comparisons with bone marrow adiposity. Front Endocrinol (Lausanne). 2016;7:69 https://doi.org/10.3389/fendo.2016.00069
Miljkovic I, Cauley JA, Wang PY, Holton KF, Lee CG, Sheu Y, et al. Abdominal myosteatosis is independently associated with hyperinsulinemia and insulin resistance among older men without diabetes. Obes (Silver Spring). 2013;21:2118–25. https://doi.org/10.1002/oby.20346
Franceschi C, Garagnani P, Parini P, Giuliani C, Santoro A. Inflammaging: A new immune-metabolic viewpoint for age-related diseases. Nat Rev Endocrinol. 2018;14:576–90. https://doi.org/10.1038/s41574-018-0059-4
Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006;444:881–7. https://doi.org/10.1038/nature05488
Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell. 2010;141:39–51. https://doi.org/10.1016/j.cell.2010.03.014